CLB logo

Core Laboratories NV (CLB) EBITDA

annual EBITDA:

$73.51M+$3.08M(+4.38%)
December 31, 2024

Summary

  • As of today (June 17, 2025), CLB annual EBITDA is $73.51 million, with the most recent change of +$3.08 million (+4.38%) on December 31, 2024.
  • During the last 3 years, CLB annual EBITDA has risen by +$9.73 million (+15.26%).
  • CLB annual EBITDA is now -80.30% below its all-time high of $373.23 million, reached on December 31, 2014.

Performance

CLB EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLBincome statement metrics

quarterly EBITDA:

$8.13M-$9.70M(-54.40%)
March 31, 2025

Summary

  • As of today (June 17, 2025), CLB quarterly EBITDA is $8.13 million, with the most recent change of -$9.70 million (-54.40%) on March 31, 2025.
  • Over the past year, CLB quarterly EBITDA has dropped by -$4.28 million (-34.48%).
  • CLB quarterly EBITDA is now -91.64% below its all-time high of $97.35 million, reached on December 31, 2014.

Performance

CLB quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLBincome statement metrics

TTM EBITDA:

$69.23M-$4.28M(-5.82%)
March 31, 2025

Summary

  • As of today (June 17, 2025), CLB TTM EBITDA is $69.23 million, with the most recent change of -$4.28 million (-5.82%) on March 31, 2025.
  • Over the past year, CLB TTM EBITDA has dropped by -$3.08 million (-4.26%).
  • CLB TTM EBITDA is now -81.45% below its all-time high of $373.23 million, reached on December 31, 2014.

Performance

CLB TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherCLBincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

CLB EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+4.4%-34.5%-4.3%
3 y3 years+15.3%+95.3%+34.5%
5 y5 years-38.4%+107.9%+1208.7%

CLB EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+25.3%-65.4%+95.3%-6.6%+38.7%
5 y5-year-38.4%+231.4%-71.2%+107.9%-12.1%+220.2%
alltimeall time-80.3%+231.4%-91.6%+107.9%-81.5%+220.2%

CLB EBITDA History

DateAnnualQuarterlyTTM
Mar 2025
-
$8.13M(-54.4%)
$69.23M(-5.8%)
Dec 2024
$73.51M(+4.4%)
$17.84M(-24.0%)
$73.51M(-0.8%)
Sep 2024
-
$23.48M(+18.7%)
$74.13M(+7.0%)
Jun 2024
-
$19.78M(+59.3%)
$69.25M(-4.2%)
Mar 2024
-
$12.41M(-32.7%)
$72.31M(+2.7%)
Dec 2023
$70.42M(+20.0%)
$18.45M(-0.8%)
$70.42M(-1.7%)
Sep 2023
-
$18.60M(-18.6%)
$71.66M(-0.3%)
Jun 2023
-
$22.84M(+117.0%)
$71.88M(+10.5%)
Mar 2023
-
$10.53M(-46.5%)
$65.04M(+10.8%)
Dec 2022
$58.69M(-8.0%)
$19.69M(+4.7%)
$58.69M(+1.9%)
Sep 2022
-
$18.82M(+17.5%)
$57.59M(+15.4%)
Jun 2022
-
$16.01M(+284.3%)
$49.91M(-3.0%)
Mar 2022
-
$4.17M(-77.6%)
$51.45M(-19.3%)
Dec 2021
$63.78M(-214.0%)
$18.60M(+67.0%)
$63.78M(-13.1%)
Sep 2021
-
$11.14M(-36.6%)
$73.42M(-6.8%)
Jun 2021
-
$17.55M(+6.4%)
$78.78M(+22.9%)
Mar 2021
-
$16.49M(-41.6%)
$64.09M(-214.6%)
Dec 2020
-$55.94M(-146.9%)
$28.24M(+71.2%)
-$55.94M(-2.9%)
Sep 2020
-
$16.50M(+477.2%)
-$57.59M(+54.9%)
Jun 2020
-
$2.86M(-102.8%)
-$37.18M(+495.5%)
Mar 2020
-
-$103.53M(-489.4%)
-$6.24M(-105.2%)
Dec 2019
$119.29M(-15.8%)
$26.59M(-27.9%)
$119.29M(+2.5%)
Sep 2019
-
$36.90M(+9.2%)
$116.40M(-3.0%)
Jun 2019
-
$33.79M(+53.6%)
$120.05M(-4.4%)
Mar 2019
-
$22.00M(-7.2%)
$125.58M(-11.4%)
Dec 2018
$141.71M(+5.4%)
$23.70M(-41.6%)
$141.71M(-9.4%)
Sep 2018
-
$40.56M(+3.2%)
$156.45M(+5.3%)
Jun 2018
-
$39.32M(+3.1%)
$148.56M(+4.0%)
Mar 2018
-
$38.13M(-0.8%)
$142.78M(+6.2%)
Dec 2017
$134.49M(+17.6%)
$38.44M(+17.7%)
$134.49M(+7.3%)
Sep 2017
-
$32.66M(-2.6%)
$125.39M(+3.7%)
Jun 2017
-
$33.54M(+12.4%)
$120.94M(+5.7%)
Mar 2017
-
$29.84M(+1.7%)
$114.38M(+0.0%)
Dec 2016
$114.32M(-39.4%)
$29.35M(+4.0%)
$114.32M(-1.2%)
Sep 2016
-
$28.21M(+4.6%)
$115.67M(-18.1%)
Jun 2016
-
$26.98M(-9.4%)
$141.19M(-16.5%)
Mar 2016
-
$29.79M(-3.0%)
$169.03M(-10.3%)
Dec 2015
$188.53M(-49.5%)
$30.69M(-42.9%)
$188.53M(-26.1%)
Sep 2015
-
$53.73M(-2.0%)
$255.18M(-14.2%)
Jun 2015
-
$54.82M(+11.2%)
$297.42M(-10.7%)
Mar 2015
-
$49.28M(-49.4%)
$333.05M(-10.8%)
Dec 2014
$373.23M(+4.0%)
$97.35M(+1.4%)
$373.23M(+0.7%)
Sep 2014
-
$95.97M(+6.1%)
$370.52M(+1.3%)
Jun 2014
-
$90.45M(+1.1%)
$365.91M(+0.7%)
Mar 2014
-
$89.46M(-5.5%)
$363.29M(+1.2%)
Dec 2013
$358.89M(+12.1%)
$94.65M(+3.6%)
$358.89M(+3.8%)
Sep 2013
-
$91.35M(+4.0%)
$345.61M(+2.8%)
Jun 2013
-
$87.83M(+3.3%)
$336.10M(+3.3%)
Mar 2013
-
$85.06M(+4.5%)
$325.47M(+1.6%)
Dec 2012
$320.20M(+17.3%)
$81.37M(-0.6%)
$320.20M(+0.8%)
Sep 2012
-
$81.84M(+6.0%)
$317.51M(+4.1%)
Jun 2012
-
$77.20M(-3.2%)
$304.94M(+4.7%)
Mar 2012
-
$79.79M(+1.4%)
$291.13M(+6.6%)
Dec 2011
$273.05M(+10.1%)
$78.67M(+13.6%)
$273.05M(+4.8%)
Sep 2011
-
$69.27M(+9.3%)
$260.46M(+1.5%)
Jun 2011
-
$63.40M(+2.8%)
$256.55M(+1.5%)
Mar 2011
-
$61.70M(-6.6%)
$252.63M(+1.8%)
Dec 2010
$248.10M
$66.09M(+1.1%)
$248.10M(+6.7%)
Sep 2010
-
$65.36M(+9.9%)
$232.61M(+7.0%)
Jun 2010
-
$59.49M(+4.1%)
$217.48M(+0.9%)
DateAnnualQuarterlyTTM
Mar 2010
-
$57.17M(+13.0%)
$215.58M(+2.3%)
Dec 2009
$210.74M(-10.6%)
$50.60M(+0.8%)
$210.80M(-6.5%)
Sep 2009
-
$50.22M(-12.8%)
$225.45M(-4.4%)
Jun 2009
-
$57.59M(+9.9%)
$235.86M(-1.2%)
Mar 2009
-
$52.38M(-19.7%)
$238.64M(+1.2%)
Dec 2008
$235.68M(+15.9%)
$65.25M(+7.6%)
$235.86M(+0.4%)
Sep 2008
-
$60.63M(+0.4%)
$234.85M(+4.1%)
Jun 2008
-
$60.37M(+21.7%)
$225.57M(+6.2%)
Mar 2008
-
$49.61M(-22.8%)
$212.37M(+3.8%)
Dec 2007
$203.32M(+43.9%)
$64.24M(+25.1%)
$204.68M(+12.4%)
Sep 2007
-
$51.35M(+8.9%)
$182.08M(+7.7%)
Jun 2007
-
$47.16M(+12.5%)
$169.06M(+7.6%)
Mar 2007
-
$41.92M(+0.7%)
$157.17M(+9.3%)
Dec 2006
$141.25M(+81.1%)
$41.64M(+8.6%)
$143.79M(+16.7%)
Sep 2006
-
$38.34M(+8.7%)
$123.25M(+19.5%)
Jun 2006
-
$35.27M(+23.6%)
$103.17M(+16.3%)
Mar 2006
-
$28.54M(+35.3%)
$88.73M(+13.8%)
Dec 2005
$77.99M(+22.0%)
$21.09M(+15.5%)
$77.99M(+2.1%)
Sep 2005
-
$18.26M(-12.3%)
$76.36M(+1.2%)
Jun 2005
-
$20.83M(+17.0%)
$75.45M(+11.5%)
Mar 2005
-
$17.81M(-8.5%)
$67.67M(+5.6%)
Dec 2004
$63.91M(+13.8%)
$19.46M(+12.1%)
$64.11M(+1.7%)
Sep 2004
-
$17.36M(+33.0%)
$63.05M(+0.5%)
Jun 2004
-
$13.05M(-8.4%)
$62.72M(+0.6%)
Mar 2004
-
$14.24M(-22.6%)
$62.32M(+10.7%)
Dec 2003
$56.16M(+38.6%)
$18.40M(+8.0%)
$56.31M(+14.2%)
Sep 2003
-
$17.03M(+34.6%)
$49.30M(+8.7%)
Jun 2003
-
$12.65M(+53.7%)
$45.34M(+1.3%)
Mar 2003
-
$8.23M(-27.7%)
$44.76M(-6.7%)
Dec 2002
$40.52M(-34.7%)
$11.39M(-12.8%)
$47.99M(+7.5%)
Sep 2002
-
$13.07M(+8.2%)
$44.63M(-14.1%)
Jun 2002
-
$12.07M(+5.3%)
$51.95M(-9.3%)
Mar 2002
-
$11.46M(+42.7%)
$57.30M(-7.8%)
Dec 2001
$62.09M(+15.5%)
$8.03M(-60.6%)
$62.13M(-12.8%)
Sep 2001
-
$20.39M(+17.1%)
$71.21M(+8.7%)
Jun 2001
-
$17.42M(+7.0%)
$65.48M(+8.8%)
Mar 2001
-
$16.29M(-4.8%)
$60.16M(+11.5%)
Dec 2000
$53.75M(+37.3%)
$17.11M(+16.6%)
$53.95M(+21.5%)
Sep 2000
-
$14.67M(+21.2%)
$44.41M(-1.6%)
Jun 2000
-
$12.10M(+20.1%)
$45.11M(+5.8%)
Mar 2000
-
$10.08M(+33.3%)
$42.64M(+9.4%)
Dec 1999
$39.16M(-31.3%)
$7.56M(-50.8%)
$38.99M(-12.7%)
Sep 1999
-
$15.37M(+59.6%)
$44.64M(-9.4%)
Jun 1999
-
$9.63M(+49.8%)
$49.27M(-8.0%)
Mar 1999
-
$6.43M(-51.3%)
$53.54M(-6.4%)
Dec 1998
$57.01M(+36.7%)
$13.21M(-33.9%)
$57.21M(-5.4%)
Sep 1998
-
$20.00M(+43.9%)
$60.50M(+16.1%)
Jun 1998
-
$13.90M(+37.6%)
$52.10M(+9.9%)
Mar 1998
-
$10.10M(-38.8%)
$47.40M(+13.1%)
Dec 1997
$41.70M(+143.9%)
$16.50M(+42.2%)
$41.90M(+39.7%)
Sep 1997
-
$11.60M(+26.1%)
$30.00M(+29.3%)
Jun 1997
-
$9.20M(+100.0%)
$23.20M(+28.2%)
Mar 1997
-
$4.60M(0.0%)
$18.10M(+4.0%)
Dec 1996
$17.10M(+29.5%)
$4.60M(-4.2%)
$17.40M(+6.7%)
Sep 1996
-
$4.80M(+17.1%)
$16.30M(+9.4%)
Jun 1996
-
$4.10M(+5.1%)
$14.90M(-49.3%)
Mar 1996
-
$3.90M(+11.4%)
$29.40M(-32.1%)
Dec 1995
$13.20M
$3.50M(+2.9%)
$43.30M(+8.8%)
Sep 1995
-
$3.40M(-81.7%)
$39.80M(+9.3%)
Jun 1995
-
$18.60M(+4.5%)
$36.40M(+104.5%)
Mar 1995
-
$17.80M
$17.80M

FAQ

  • What is Core Laboratories NV annual EBITDA?
  • What is the all time high annual EBITDA for Core Laboratories NV?
  • What is Core Laboratories NV annual EBITDA year-on-year change?
  • What is Core Laboratories NV quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Core Laboratories NV?
  • What is Core Laboratories NV quarterly EBITDA year-on-year change?
  • What is Core Laboratories NV TTM EBITDA?
  • What is the all time high TTM EBITDA for Core Laboratories NV?
  • What is Core Laboratories NV TTM EBITDA year-on-year change?

What is Core Laboratories NV annual EBITDA?

The current annual EBITDA of CLB is $73.51M

What is the all time high annual EBITDA for Core Laboratories NV?

Core Laboratories NV all-time high annual EBITDA is $373.23M

What is Core Laboratories NV annual EBITDA year-on-year change?

Over the past year, CLB annual EBITDA has changed by +$3.08M (+4.38%)

What is Core Laboratories NV quarterly EBITDA?

The current quarterly EBITDA of CLB is $8.13M

What is the all time high quarterly EBITDA for Core Laboratories NV?

Core Laboratories NV all-time high quarterly EBITDA is $97.35M

What is Core Laboratories NV quarterly EBITDA year-on-year change?

Over the past year, CLB quarterly EBITDA has changed by -$4.28M (-34.48%)

What is Core Laboratories NV TTM EBITDA?

The current TTM EBITDA of CLB is $69.23M

What is the all time high TTM EBITDA for Core Laboratories NV?

Core Laboratories NV all-time high TTM EBITDA is $373.23M

What is Core Laboratories NV TTM EBITDA year-on-year change?

Over the past year, CLB TTM EBITDA has changed by -$3.08M (-4.26%)
On this page